Profil
Jayant Aphale held several positions in different firms throughout his career.
He started as Vice President at Acambis Plc in 2006 and then moved to Enobia Pharma, Inc. as Vice President-Manufacturing & Process Sciences from 2008 to 2010.
In 2010, he worked as Vice President at GSK Plc for a brief period.
From 2011 to 2018, he served as Senior Vice President-Technical Operations at Sarepta Therapeutics, Inc. In 2018, he became EVP-Technical Operations at Gritstone bio, Inc. for a year.
In 2011, he was briefly the President of Apex Cmc Advisors LLC.
Dr. Aphale received his undergraduate degree from the University of Pune, his doctorate from The Ohio State University, and his MBA from The University of North Carolina at Asheville.
Anciens postes connus de Jayant Aphale
| Sociétés | Poste | Fin |
|---|---|---|
| GRITSTONE BIO, INC. | Corporate Officer/Principal | 01/03/2019 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2018 |
| Apex Cmc Advisors LLC | President | 01/12/2011 |
| GSK PLC | President | 01/11/2010 |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | - |
Formation de Jayant Aphale
| The Ohio State University | Doctorate Degree |
| University of Pune | Undergraduate Degree |
| The University of North Carolina at Asheville | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| GRITSTONE BIO, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Health Technology |
| Apex Cmc Advisors LLC |
